Terveystalo Oyj (HEL:TTALO)
Finland flag Finland · Delayed Price · Currency is EUR
7.60
+0.02 (0.26%)
Apr 28, 2026, 6:29 PM EET

Terveystalo Oyj Earnings Call Transcripts

Fiscal Year 2026

  • Revenue and profitability declined sharply in Q1 2026 amid an exceptionally weak healthcare market, but operational efficiency and digital investments remained strong. Management expects gradual recovery from H2, with full-year EBIT guidance maintained and key growth initiatives underway.

Fiscal Year 2025

Fiscal Year 2024

  • Record financial and quality results in 2024, with strong revenue and EBITDA growth, improved margins, and robust cash flow. Guidance for 2025 targets further margin and EPS growth, supported by ongoing efficiency and technology investments.

  • CMD 2024

    Turnaround has been delivered ahead of schedule, with a structurally stronger, less risky business and a confident shift to balanced, organic growth. Digitalization, integrated care, and targeted investments drive profitability, while new financial targets focus on 10% EPS growth and high dividends.

  • A leading Nordic healthcare provider reported strong profitability and growth, driven by digital integration, operational improvements, and resilience in a challenging market. Future plans focus on incremental growth, technology investment, and leveraging demographic and funding trends.

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018

Powered by